Montreal Neurological Institute scientists discover a new mechanism driving spread of cancer A protein commonly found in human cells could be an important switch that activates cancer cell metastasis, according to a new study by researchers at the Montreal Neurological Institute and Hospital - The Neuro at McGill University and the MUHC. The finding focuses attention on a biological mechanism that until now was largely overlooked. The discovery of the protein’s effect significantly expands our understanding of epithelial cancers such as breast and lung cancer.
Improves tumour surgeries and extends survival times for brain cancer patients VIDEO: http://bit.ly/1EYjsTV
A new study of over 3,400 Canadian women provides further evidence that exposure to air-pollution may increase the risk of developing breast cancer, especially among women who have not yet had their menopause.
My guest next Sunday on my radio show is Dr. David Gorski, surgical oncologist and champion of science-based medicine. The topic? What else? Quack cancer remedies. But we will also discuss legitimate treatments. You can catch the action at 3 PM Eastern time on CJAD 800 in Montreal or on the web. Just go to the CJAD website and click on" listen live."
The McGill Division of Cancer Epidemiology has recently launched the CATCH study to test the effectiveness of a Carrageenan-based gel in preventing the tranmission of HPV. Carrageenan is derived from red algae, and commonly used as a thickening agent in food products. It could represent an inexpensive method of prevention against the virus, whereas the vaccine and screening procedures are considerably more expensive.
Investment In a Quebec Public-Private Partnership to Support the Use of Personalized Medicine Solutions in the Treatment of Cancer Patients
The Government of Québec announced today a $10 million investment in the Personalized Medicine Partnership for Cancer (PMPC). This public-private partnership will be focused on establishing an integrated approach for the development and implementation of clinical biomarkers and other personalized healthcare solutions to improve the outcome and cost-efficiency of healthcare services provided to cancer patients in the province of Québec and abroad.